Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment.

International journal of molecular sciences - 31 Jan 2022

Das Srijit, Juliana Norsham, Yazit Noor Anisah Abu, Azmani Sahar, Abu Izuddin Fahmy

Abstract excerpt

Multiple myeloma (MM) is a malignant hematological disease. The disease is characterized by the clonal proliferation of malignant plasma cells in the bone marrow. MM accounts for 1.3% of all malignancies and has been increasing in incidence all over the world. Various genetic abnormalities, mutations, and translocation, including epigenetic modifications, are known to contribute to the disease's pathophysiology....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Products
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Epigenesis, Genetic

Share to Multiple Myeloma

Share to Prognosis

Share to Translocation, Genetic

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 35163567
DOI: 10.3390/ijms23031649
PMCID: PMC8836148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment.PMID 35163567Read ↗

Multiple myeloma.Semantic proximity Read ↗

The Role of Epigenetics in the Development and Progression of Multiple MyelomaSemantic proximity Read ↗

Biology and therapy of multiple myelomaSemantic proximity Read ↗

Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic ModificationsSemantic proximity Read ↗

Epidemiology, genetics and treatment of multiple myeloma and precursor diseases.Semantic proximity Read ↗

Molecular pathogenesis of multiple myeloma: basic and clinical updatesSemantic proximity Read ↗

Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanismsSemantic proximity Read ↗

Research Progress of Protein Arginine Methyltransferases (PRMTs) in Multiple Myeloma: From Molecular Mechanisms to Targeted TherapySemantic proximity Read ↗

Pathogenesis of MyelomaSemantic proximity Read ↗

Risk Factors for Multiple Myeloma: A Systematic Review of Meta-Analyses.Semantic proximity Read ↗

NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple MyelomaSemantic proximity Read ↗

Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple MyelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.